Related Experiment Videos
Summary
Most tumors trigger an immune response, but it rarely stops cancer growth. Early immune reactions may even fuel tumor development, challenging the idea of immunologic surveillance.
Area of Science:
- Oncology
- Immunology
- Cancer Research
Background:
- Neoplasms (tumors) typically elicit an immune response in the host.
- This immune response is generally ineffective at controlling tumor progression.
- The concept of immunologic surveillance may not accurately reflect tumor-host interactions.
Purpose of the Study:
- To evaluate the effectiveness of host immune responses in limiting tumor growth.
- To investigate the role of early immune reactions in cancer development.
- To reassess the validity of the immunologic surveillance hypothesis.
Main Methods:
- Analysis of host immune responses to various neoplasms.
- Examination of the impact of early immune stimulation on nascent tumors.
- Review of exceptional tumor systems with effective immune reactions.
Main Results:
- Immune responses to most neoplasms are seldom effective in limiting tumor growth.
- Early, weak immune responses to nascent tumors can paradoxically stimulate their growth.
- Truly tumor-limiting immune reactions are rare, late, and ineffectual when they occur.
Conclusions:
- The host immune response is generally insufficient to prevent lethal cancer.
- The theory of immunologic surveillance is likely inaccurate, as early responses may promote rather than inhibit tumors.
- While immunity is crucial for controlling oncogenic viruses, it rarely determines the outcome of established transformed cells becoming lethal cancers.